Fyr Bio
17 employees on LinkedIn · 1 known investors
Find your way into Fyr Bio
Sign up to see every warm intro you have to Fyr Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fyr Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
FYR develops a platform to analyze extracellular vesicles from blood samples and generate multiomics insights for disease understanding and personalized treatment selection. The company serves biomedical researchers, drug developers, and clinical diagnostics organizations.
Investors · 1
Two Bear Capitallisted by Two Bear CapitalWhitefish · $3M – $10M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Fyr Bio do?
- FYR develops a platform to analyze extracellular vesicles from blood samples and generate multiomics insights for disease understanding and personalized treatment selection. The company serves biomedical researchers, drug developers, and clinical diagnostics organizations.
- Who are Fyr Bio's investors?
- Fyr Bio's investors include Two Bear Capital.

